ATE477272T1 - Verwendung von stefin a als gerüstprotein - Google Patents

Verwendung von stefin a als gerüstprotein

Info

Publication number: ATE477272T1
Authority: AT; Austria
Prior art keywords: stefin; scaffold; mutations; relates; leu73
Prior art date: 2005-06-10

Application number

AT06744166T

Other languages

English (en)

Inventor

Robbie Woodman

Johannes Yeh

Sophie Laurenson

Ferrigno Paul Ko

Original Assignee

Medical Res Council

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-10

Filing date

2006-06-08

Publication date

2010-08-15

2005-06-10 Priority claimed from GB0511873A external-priority patent/GB0511873D0/en

2006-05-04 Priority claimed from GB0608836A external-priority patent/GB0608836D0/en

2006-06-08 Application filed by Medical Res Council filed Critical Medical Res Council

2010-08-15 Application granted granted Critical

2010-08-15 Publication of ATE477272T1 publication Critical patent/ATE477272T1/de

Links

102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
230000035772 mutation Effects 0.000 abstract 5
101710167800 Capsid assembly scaffolding protein Proteins 0.000 abstract 4
101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 abstract 4
101710204410 Scaffold protein Proteins 0.000 abstract 4
102220591835 Charged multivesicular body protein 3_V48D_mutation Human genes 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
102220237123 rs74315443 Human genes 0.000 abstract 3
102000012193 Cystatin A Human genes 0.000 abstract 2
108010061641 Cystatin A Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
206010017533 Fungal infection Diseases 0.000 abstract 1
101000921786 Homo sapiens Cystatin-A Proteins 0.000 abstract 1
102000023732 binding proteins Human genes 0.000 abstract 1
108091008324 binding proteins Proteins 0.000 abstract 1
102000045247 human CSTA Human genes 0.000 abstract 1
230000037431 insertion Effects 0.000 abstract 1
238000003780 insertion Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
108010091748 peptide A Proteins 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Crystallography & Structural Chemistry (AREA)
Bioinformatics & Computational Biology (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AT06744166T 2005-06-10 2006-06-08 Verwendung von stefin a als gerüstprotein ATE477272T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0511873A GB0511873D0 (en)	2005-06-10	2005-06-10	Scaffold
GB0608836A GB0608836D0 (en)	2006-05-04	2006-05-04	Scaffold
PCT/GB2006/002115 WO2006131749A2 (en)	2005-06-10	2006-06-08	Scaffold

Publications (1)

Publication Number	Publication Date
ATE477272T1 true ATE477272T1 (de)	2010-08-15

Family

ID=37314237

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06744166T ATE477272T1 (de)	2005-06-10	2006-06-08	Verwendung von stefin a als gerüstprotein

Country Status (9)

Country	Link
US (2)	US8063019B2 (de)
EP (1)	EP1904529B1 (de)
JP (1)	JP4989638B2 (de)
AT (1)	ATE477272T1 (de)
AU (1)	AU2006256530B2 (de)
CA (1)	CA2610976C (de)
DE (1)	DE602006016133D1 (de)
DK (1)	DK1904529T3 (de)
WO (1)	WO2006131749A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8063019B2 (en) *	2005-06-10	2011-11-22	Medical Research Council	Scaffold polypeptides for heterologous peptide display
GB0807065D0 (en)	2008-04-18	2008-05-21	Univ Leeds	Novel scaffolds
GB201302597D0 (en)	2013-02-14	2013-04-03	Univ Leeds	Novel Synthetic Proteins
HK1231496A1 (zh) *	2014-06-20	2017-12-22	豪夫迈．罗氏有限公司	基於chagasin的支架组合物、方法和应用
EP3405579A1 (de)	2016-01-22	2018-11-28	Modernatx, Inc.	Boten-ribonukleinsäuren (mrna) zur herstellung intrazellulärer bindungspolypeptide und verfahren zur verwendung davon
EP4575499A3 (de)	2017-01-04	2025-07-09	MGI Tech Co., Ltd.	Schrittweise sequenzierung durch nichtmarkierte reversible terminatoren oder natürliche nukleotide
CN110462403B (zh)	2017-05-19	2024-01-12	菲利普莫里斯生产公司	用于区分受试者的吸烟状况的诊断测试
GB201710973D0 (en) *	2017-07-07	2017-08-23	Avacta Life Sciences Ltd	Scaffold proteins
EP4045536A4 (de) *	2019-10-16	2023-11-01	Lg Chem, Ltd.	Neonatale fc-rezeptor bindende affimere
GB202101299D0 (en)	2020-06-09	2021-03-17	Avacta Life Sciences Ltd	Diagnostic polypetides and methods
EP4225933A4 (de)	2020-10-09	2024-11-27	BGI Shenzhen Co., Limited	Verfahren und zusammensetzungen zur biolumineszenzbasierten sequenzierung
EP4477665A4 (de) *	2022-02-10	2025-08-20	Affyxell Therapeutics Co Ltd	Stefin-a-proteinvarianten mit spezifischer bindung an cd40l und verwendungen davon
EP4499664A2 (de) *	2022-03-24	2025-02-05	Agency for Science, Technology and Research	Herstellung von peptiden unter verwendung der evolution von peptidepitoplinkern
WO2024141788A1 (en) *	2022-12-29	2024-07-04	Affyxell Therapeutics Co., Ltd.	Genetically modified stem cells expressing exogenous binding agents and uses thereof
GB202403780D0 (en)	2024-03-15	2024-05-01	Avacta Life Sciences Ltd	Polypeptides and methods for detecting and quantifying small molecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996016173A2 (en) *	1994-11-21	1996-05-30	The University Of Leeds	Modified proteinase inhibitors
SK692001A3 (en) *	1998-07-20	2001-12-03	M & E Biotech As	Novel methods for the identification of ligand and target biomolecules
ATE513917T1 (de)	2003-11-06	2011-07-15	Genencor Int	Bakterielle expression von proteaseinhibitoren und varianten davon
US8063019B2 (en) *	2005-06-10	2011-11-22	Medical Research Council	Scaffold polypeptides for heterologous peptide display

2006
- 2006-06-08 US US11/917,057 patent/US8063019B2/en active Active
- 2006-06-08 WO PCT/GB2006/002115 patent/WO2006131749A2/en not_active Ceased
- 2006-06-08 JP JP2008515292A patent/JP4989638B2/ja not_active Expired - Fee Related
- 2006-06-08 DK DK06744166.7T patent/DK1904529T3/da active
- 2006-06-08 EP EP06744166A patent/EP1904529B1/de active Active
- 2006-06-08 AT AT06744166T patent/ATE477272T1/de active
- 2006-06-08 CA CA2610976A patent/CA2610976C/en active Active
- 2006-06-08 DE DE602006016133T patent/DE602006016133D1/de active Active
- 2006-06-08 AU AU2006256530A patent/AU2006256530B2/en not_active Ceased
2011
- 2011-09-23 US US13/243,318 patent/US8481491B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2610976C (en)	2020-11-24
WO2006131749A2 (en)	2006-12-14
DE602006016133D1 (de)	2010-09-23
US20080207509A1 (en)	2008-08-28
AU2006256530A1 (en)	2006-12-14
US8481491B2 (en)	2013-07-09
JP4989638B2 (ja)	2012-08-01
CA2610976A1 (en)	2006-12-14
WO2006131749A3 (en)	2007-05-18
EP1904529A2 (de)	2008-04-02
US20120190819A1 (en)	2012-07-26
US8063019B2 (en)	2011-11-22
DK1904529T3 (da)	2010-11-15
EP1904529B1 (de)	2010-08-11
JP2008541776A (ja)	2008-11-27
AU2006256530B2 (en)	2012-12-20

Legal Events

Date

Code

Title

Description

2011-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1904529

Country of ref document: EP

Publication	Publication Date	Title
ATE477272T1 (de)	2010-08-15	Verwendung von stefin a als gerüstprotein
ATE540111T1 (de)	2012-01-15	Hla-dr-bindendes antigenpeptid, das von wt1 abgeleitet ist
DK1844150T3 (da)	2012-05-29	Rekombinant ekspression af proteiner i en to-kædet form med disulfidbroer
ATE482972T1 (de)	2010-10-15	Tgf-beta1-bindende und geträgerte peptide
ATE309536T1 (de)	2005-11-15	Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DK1194560T3 (da)	2007-11-05	Antigene Neisseria-peptider
Claeys et al.	1976	Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin
DE602005020165D1 (de)	2010-05-06	Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
DE50112802D1 (de)	2007-09-13	Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE60230456D1 (de)	2009-01-29	Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
DK1530637T3 (da)	2010-05-31	Carlsberg-subtilisin-proteiner med nedsat immunogenitet
DE602004031642D1 (de)	2011-04-14	Methode zur verbesserung der wirksamkeit von biologischen antwort-verändernden proteinen und exemplarische muteine
DE60335726D1 (de)	2011-02-24	Chromoprotein und fluoroproteine
DE602004015142D1 (de)	2008-08-28	Antiangiogene peptide zur behandlung oder vorbeugung von endometriose
DE60028248D1 (de)	2006-06-29	Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
ATE503834T1 (de)	2011-04-15	Bibliotheken rekombinanter chimärischer proteine
WO2007013358A3 (en)	2007-07-05	Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
ATE466876T1 (de)	2010-05-15	Immunogene konstrukte
ATE538806T1 (de)	2012-01-15	Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
DK2186898T3 (da)	2015-06-22	Blomstrings-induktion
SG170757A1 (en)	2011-05-30	Polypeptide having esterase activity and recombinant esterase and use thereof
FI20031050A7 (fi)	2005-01-10	Menetelmä proteiinien katkaisuun
DE602004019556D1 (de)	2009-04-02	Neues plexin-polypeptid, dieses codierende dna und verwendung davon
NZ603077A (en)	2014-05-30	Biological materials and uses thereof
ATE529437T1 (de)	2011-11-15	Verfahren zur sauerstoff-regulierten produktion von recombinanter staphylokinase